Basic Information
Basic information for LINC00343-218-19aa-2
Peptide Name LINC00343-218-19aa-2
Genome Position chr13:105728697-105728727,105730315-105730340[+]
Species Human
Peptide Sequence MDYILYKAVWGEKIEFGHR
Peptide Length 19
Unique No (LINC00343-212-19aa-2,LINC00343-213-19aa,LINC00343-214-19aa,LINC00343-217-19aa,LINC00343-219-19aa,LINC00343-220-19aa,LINC00343-225-19aa,LINC00343-228-19aa,LINC00343-239-19aa,LINC00343-249-19aa,LINC00343-263-19aa,LINC00343-269-19aa,LINC00343-270-19aa,LINC00343-273-19aa,LINC00343-274-19aa,LINC00343-280-19aa,LINC00343-287-19aa,LINC00343-295-19aa,LINC00343-311-19aa,LINC00343-313-19aa,LINC00343-321-19aa,LINC00343-322-19aa,LINC00343-326-19aa,LINC00343-328-19aa,LINC00343-329-19aa,LINC00343-331-19aa)
Grand Average of Hydropathicity -0.3579
Relative Molecular Mass 2679.99
Experimental Evidences no
lncRNA ID/Name ENSG00000226620;LINC00343
Transcript ID/Name ENST00000654132;LINC00343-218
Transcript Length 2295
Coding Ability 0.4885
DNA Sequence Corresponding to Peptide ATGGATTACATCCTCTATAAAGCAGTCTGGGGTGAGAAAATCGAATTTGGACACCGT
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :